+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Chemoprotective ursodeoxycholic acid, but not chemopromotional cholic acid, prevents the activation of PKC-beta-2 and PKC-zeta in the azoxymethane model of colon cancer



Chemoprotective ursodeoxycholic acid, but not chemopromotional cholic acid, prevents the activation of PKC-beta-2 and PKC-zeta in the azoxymethane model of colon cancer



Gastroenterology 108(4 Suppl. ): A550




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030513524

Download citation: RISBibTeXText


Related references

Differential effects of tumour promoting bile acid deoxycholic acid and chemoprotective ursodeoxycholic acid on protein kinase c beta 1, epsilon and delta and transcription factors, nf kappab and ap 1 in human colon cancer cells. Digestive Disease Week Abstracts & Itinerary Planner : Abstract No S992, 2003

Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Cancer Epidemiology Biomarkers and Prevention 11(12): 1653-1662, 2002

Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acid-induced activation of NF-kappaB and AP-1 in human colon cancer cells. International Journal of Cancer 118(3): 532-539, 2006

Mixed monolayer formation of bile acid mixtures chenodeoxycholic acid with ursodeoxycholic acid and cholic acid with beta muricholic acid. Journal of Colloid & Interface Science 149(1): 216-225, 1992

Mechanism of action of chemoprotective ursodeoxycholate in the azoxymethane model of rat colonic carcinogenesis: potential roles of protein kinase C-alpha, -beta II, and -zeta. Cancer Research 55(22): 5257-5264, 1995

Delta 4-3-oxosteroid 5 beta-reductase deficiency: failure of ursodeoxycholic acid treatment and response to chenodeoxycholic acid plus cholic acid. Gut 38(4): 623-628, 1996

Sub cellular pathology of rat liver in cholestasis and choleresis induced by bile salts part 1 effects of litho cholic 3 beta hydroxy 5 cholenoic acid cholic acid and dehydro cholic acid. Laboratory Investigation 36(3): 249-258, 1977

Effect of simvastatin ursodeoxycholic acid and simvastatin plus ursodeoxycholic acid on biliary lipid secretion and cholic acid kinetics in nonfamilial hypercholesterolemia. Hepatology 15(6): 1072-1078, 1992

Reduction of aberrant crypt foci induced in rat colon with azoxymethane or methylnitrosourea by feeding cholic acid. Cancer Letters 68(1): 15-24, 1993

Comparative formation of litho cholic acid from urso deoxy cholic acid and cheno deoxy cholic acid in the human colon. Gastroenterology 79(5 Part 2): 1004, 1980

Chemopreventive effects of 6-fluoro ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci in rat colon. Gastroenterology 112(4 Suppl. ): A579, 1997

The significance of the bacterial steroid degradation for the etiology of large bowel cancer 8. transformation of cholic acid cheno deoxy cholic acid and deoxy cholic acid by lecithinase lipase negative clostridia. Zentralblatt fuer Bakteriologie Mikrobiologie und Hygiene Abt 1 Originale B Hygiene Umwelthygiene Krankenhaushygiene Arbeitshygiene Praeventive Medizin 174(1-2): 91-104, 1981

Characterization of liver cholic acid coenzyme A ligase activity. Evidence that separate microsomal enzymes are responsible for cholic acid and fatty acid activation. Journal of Biological Chemistry 252(4): 1167-1171, 1977

Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+. Journal of Medical Investigation 49(1-2): 67-73, 2002

Effect of ursodeoxycholic acid in an experimental colon cancer model. Revista Espanola de Enfermedades Digestivas 99(9): 491-496, 2007